Lev Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Lev Pharmaceuticals Ownership

Who owns Lev Pharmaceuticals?

Lev Pharmaceuticals is owned by ViroPharma. It was acquired on October 21, 2008.

Lev Pharmaceuticals Business Overview

Where is Lev Pharmaceuticals headquartered?

Lev Pharmaceuticals is headquartered in New York, New York.

How many employees does Lev Pharmaceuticals have?

Lev Pharmaceuticals has 27 employees.

What sector is Lev Pharmaceuticals in?

Lev Pharmaceuticals is a life science company.

When was Lev Pharmaceuticals founded?

Lev Pharmaceuticals was founded in 2003.

Life Science M&A Summary in 2008

Out of 60 sectors in the Mergr database, life science ranked 10 in number of deals in 2008. The largest life science acquisition in 2008 was Alpharma Pharmaceuticals - which was acquired by King Pharmaceuticals for $16.0B.

Join Mergr to view all 128 acquisitions of life science companies in 2008, including 24 acquisitions by private equity firms, and 104 by strategics.

Lev Pharmaceuticals, Inc.

122 West 42nd Street,
New York, New York 10168
United States,
(212) 682-3096

Lev Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.